Emerald Health Pharmaceuticals Receives Safety Review Committee Approval to Proceed to Final Cohorts of EHP-101 Phase 2a Systemic Sclerosis Trial
January 11, 2023 07:00 ET
|
Emerald Health Pharmaceuticals
SAN DIEGO, CA, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (“EHP” or the “Company”), a clinical-stage biopharmaceutical company developing a new class of medicines to treat...
Emerald Health Pharmaceuticals Receives IND Clearance to Begin Phase 2 Clinical Trial of EHP-101 for Relapsing Forms of Multiple Sclerosis
January 11, 2022 09:00 ET
|
Emerald Health Pharmaceuticals
SAN DIEGO, CA, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (EHP or the Company), a clinical-stage biopharmaceutical company developing a new class of medicines to treat...
Emerald Health Pharmaceuticals Announces Final Closing Date For its Regulation A+ Offering
March 09, 2021 08:30 ET
|
Emerald Health Pharmaceuticals
SAN DIEGO, CA, March 09, 2021 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (EHP, or, the Company), a clinical-stage biotechnology company developing a new class of medicines to treat...
Emerald Health Pharmaceuticals Announces Closing Date For its Current Regulation A+ Offering Round
October 19, 2020 08:30 ET
|
Emerald Health Pharmaceuticals
SAN DIEGO, CA, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (EHP), a clinical-stage biotechnology company developing a new class of medicines to treat diseases with unmet...
Emerald Health Therapeutics’ Pure Sunfarms Joint Venture Begins Shipping Branded Products to Manitoba
July 24, 2020 07:00 ET
|
Emerald Health Therapeutics, Inc.
Pure Sunfarms remains top-selling dried cannabis brand with Ontario Cannabis Store1 and achieves sales records in July VANCOUVER, July 24, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics,...
Emerald Health Therapeutics to Host 2019 Fourth Quarter and Year End Financial Results Conference Call on Thursday, May 14, 2020 at 10:30 AM ET
May 08, 2020 07:00 ET
|
Emerald Health Therapeutics, Inc.
VANCOUVER, May 08, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that, further to its news release on April 29th, Emerald will...
Emerald Health Pharmaceuticals Receives Fast Track Designation from US FDA for EHP-101 in the Treatment of Systemic Sclerosis
March 03, 2020 08:30 ET
|
Emerald Health Pharmaceuticals
First-in-class product candidate in Phase 2 clinical development now has Fast Track and Orphan designations SAN DIEGO, CA, March 03, 2020 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc....